The 2025 Shenzhen Brain-Computer Interface & Human-Computer Interaction Expo has become a focal point for global tech observers as China showcases its latest advancements in neurotechnology. Running this week in southern China's innovation hub, the event highlights the Chinese mainland's growing leadership in brain-computer interface (BCI) systems and cognitive science applications.
New Alliance for Brain Science Innovation
A centerpiece of the expo is the establishment of the Greater Bay Area AI Innovation Alliance for Brain Science, bringing together academic institutions and tech enterprises. The coalition will concentrate on three strategic areas: next-generation neurological therapeutics, BCI-enabled medical devices, and AI-driven brain health solutions aimed at addressing central nervous system disorders.
Major Funding Boost
Organizers announced an 11.6-billion-yuan ($165 million) industry fund to accelerate commercialization of brain science innovations. The first round of investment agreements signed at the expo targets projects spanning fundamental research to clinical applications, with government capital designed to attract additional private-sector participation.
Exhibits demonstrate practical applications of BCI technology, including neural rehabilitation systems and AI-enhanced diagnostic platforms. These developments position Shenzhen as a key node in China's national innovation strategy, particularly in advanced biomedical technologies.
